Clearmind Medicine (NASDAQ:CMND – Get Free Report) released its quarterly earnings results on Thursday. The company reported ($0.24) EPS for the quarter, Zacks reports.
Clearmind Medicine Stock Performance
Shares of Clearmind Medicine stock opened at $1.14 on Friday. The firm has a market capitalization of $4.86 million, a P/E ratio of -0.61 and a beta of 1.02. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.01. The company has a 50 day moving average price of $1.35 and a 200 day moving average price of $1.36. Clearmind Medicine has a 52 week low of $0.95 and a 52 week high of $2.30.
Clearmind Medicine Company Profile
Further Reading
- Five stocks we like better than Clearmind Medicine
- Stock Market Sectors: What Are They and How Many Are There?
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
- What is Put Option Volume?
- Why Costco Stock Is Poised to Hit $1,000 Again Soon
Receive News & Ratings for Clearmind Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clearmind Medicine and related companies with MarketBeat.com's FREE daily email newsletter.